Insulin Therapy News

• Alert FDA Okays Tidepool Loop App to Help Guide Insulin Delivery Prescription-only device works with compatible continuous glucose monitors and insulin pumps for people with type 1 diabetes aged 6 years or older.
  Medscape Medical News, January 24, 2023
• High-Deductible Health Plans Detrimental for Those With Diabetes Individuals forced to switch to high-deductible plans appear to ration care, leading to more hypo- and hyperglycemic events.
  Medscape Medical News, January 23, 2023
• Arizona Dad Seeking Answers After Son Dies in State Care "They couldn't keep him alive for two weeks, two weeks," the father told the Associated Press while on a recent furlough from jail.
  Associated Press, January 17, 2023
• Oramed Oral Insulin Fails to Meet Goal in Type 2 Diabetes Top-line results from phase 3 trial of ORMD-0801 show that the oral insulin product didn't meet the phase 3 trial's endpoints for change from baseline hemoglobin A1c at 26 weeks.
  Medscape Medical News, January 12, 2023
• Latest Steps Toward Reducing US Insulin Cost Begin in 2023 Co-pay caps for Medicare beneficiaries begin in 2023, while new federal legislation, state laws, and new insulin manufacturers all eyed as more possible solutions.
  Medscape Medical News, January 06, 2023
• IDF 2022 New Efforts to Aid Those With Diabetes in Humanitarian Crises A recently launched multisector partnership is gearing up to provide lifesaving assistance for people with diabetes in natural and man-made disaster situations.
  Medscape Medical News, December 28, 2022
• A Starting Point for Precision Medicine in Type 1 Diabetes New evidence about the epidemiology, genetics, and possible constituent causes of type 1 diabetes is offering clues to precision medicine for this disorder.
  Medscape Medical News, December 16, 2022
• Alert FDA Okays Dexcom G7 Continuous Glucose Monitoring System The new version has several advantages over the G6, including smaller size, shorter warm-up time, and a 12-hour grace period before expiring.
  Medscape Medical News, December 08, 2022
• Update Stresses New Strategies for Hypoglycemia Management The latest guideline from The Endocrine Society updates recommendations to reflect new treatment options for hypoglycemia prevention and treatment in diabetes.
  Medscape Medical News, December 08, 2022
• Remission From Type 2 Diabetes: Myth or Reality? Although helping patients establish glycemic control is doctors' primary concern, an international consensus suggests that current medicines make remission possible.
  Medscape Medical News, December 06, 2022
• Fake Twitter Account Falsely Said Eli Lilly Was Giving Away Insulin The problem started on Thursday morning when a parody Twitter account with the handle @elilillyandco said, "We are excited to announce that insulin is free now," Forbes reported.
  WebMD Health News, November 14, 2022
• Insulin Rationing Common, 'Surprising' Even Among Privately Insured Nationwide data reveal that Americans with private insurance are more likely to ration insulin than those with public health insurance and the insulin-treated diabetes population overall.
  Medscape Medical News, October 17, 2022
• Patient With Diabetes Creates DIY Insulin-Delivery Device Nina Tousch is one of many patients with diabetes who have created their own automated insulin-delivery devices using freely available software.
  Medscape Medical News, October 10, 2022
• New Advice on Artificial Pancreas Insulin Delivery Systems A new joint American and European consensus statement covers the benefits, limitations, and challenges of automated insulin delivery systems and provides recommendations for use.
  Medscape Medical News, October 06, 2022
• EASD 2022 Is Continuous Glucose Monitoring for Everyone With Diabetes? At the EASD annual meeting, two experts debated '...and CGM for all," with nuanced takes regarding people with type 2 diabetes not on insulin.
  Medscape Medical News, October 05, 2022
• EASD 2022 Once-Weekly Insulin Promising in Phase 3 Trial in Type 2 Diabetes Novo Nordisk's insulin icodec was superior in lowering A1c compared with daily degludec without increasing the risk for moderate or severe hypoglycemia in adults with type 2 diabetes already taking basal insulin.
  Medscape Medical News, September 29, 2022
• EASD 2022 Will Insulin Treatment Disappear in Type 2 Diabetes? At EASD, two experts debate the future of insulin therapy for type 2 diabetes.
  Medscape Medical News, September 28, 2022
• FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps The FDA on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic were vulnerable to cyberattacks and that hackers could potentially hamper insulin delivery by accessing the device.
  Reuters Health Information, September 20, 2022
• Artificial Pancreas at Diagnosis Didn't Slow T1D Progression Use of an automated insulin delivery system at type 1 diabetes onset didn't prevent further C-peptide decline, but glycemia wasn't completely normalized.
  Medscape Medical News, September 07, 2022
• DIY Artificial Pancreas Safe and Effective, Show Published Data Results from the CREATE trial demonstrated efficacy and safety, and 'further support the feasibility of implementing an open-source system,' an editorialist writes.
  Medscape Medical News, September 07, 2022